SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+6.94%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.32B
AUM Growth
+$1.32B
(-7%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-9.69%
Top 10 Holdings %
Top 10 Hldgs %
27.68%
Holding
135
New
38
Increased
26
Reduced
44
Closed
22
Top Buys
| 1 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
$33.4M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$25.4M |
| 3 |
Alignment Healthcare
ALHC
|
$23.1M |
| 4 |
Vor Biopharma
VOR
|
$23.1M |
| 5 |
NVTA
Invitae Corporation
NVTA
|
$21.9M |
Top Sells
| 1 |
Tandem Diabetes Care
TNDM
|
$38.5M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$35M |
| 3 |
Labcorp
LH
|
$31.5M |
| 4 |
Exelixis
EXEL
|
$29.6M |
| 5 |
AFIB
Acutus Medical, Inc. Common Stock
AFIB
|
$28.3M |
Sector Composition
| 1 | Healthcare | 93.61% |
| 2 | Industrials | 3.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Nkarta
NKTX
$149M
| $5.56M | 0.42% |
+169,050
| New | +$5.56M |
|
77
Amgen
AMGN
$153B
| $5.3M | 0.4% |
21,303
-1,150
| -5% | -$286K |
|
|
TLIS
78
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $5.21M | 0.39% |
+405,094
| New | +$5.21M |
|
|
BLU
79
DELISTED
BELLUS Health Inc.
BLU
| $4.9M | 0.37% |
1,274,940
-422,000
| -25% | -$1.62M |
|
80
Thermo Fisher Scientific
TMO
$183B
| $4.75M | 0.36% |
10,400
| – | – |
|
|
ONCR
81
DELISTED
Oncorus, Inc.
ONCR
| $4.66M | 0.35% |
+335,000
| New | +$4.66M |
|
82
Boston Scientific
BSX
$159B
| $3.97M | 0.3% |
102,726
+52,500
| +105% | +$2.03M |
|
83
Danaher
DHR
$143B
| $3.78M | 0.29% |
16,775
+9,275
| +124% | +$2.09M |
|
84
Biogen
BIIB
$20.8B
| $3.49M | 0.26% |
12,482
-300
| -2% | -$83.9K |
|
85
CryoPort
CYRX
$426M
| $3.49M | 0.26% |
+67,034
| New | +$3.49M |
|
86
Stryker
SYK
$149B
| $3.34M | 0.25% |
13,700
+5,900
| +76% | +$1.44M |
|
87
Pfizer
PFE
$141B
| $3.17M | 0.24% |
87,400
-7,500
| -8% | -$272K |
|
|
88
Tandem Diabetes Care
TNDM
$834M
| $3.1M | 0.23% |
35,100
-436,718
| -93% | -$38.5M |
|
89
Personalis
PSNL
$430M
| $2.97M | 0.22% |
+120,500
| New | +$2.97M |
|
90
Vertex Pharmaceuticals
VRTX
$102B
| $2.43M | 0.18% |
11,321
-5,600
| -33% | -$1.2M |
|
91
Cytosorbents Corp
CTSO
$61.5M
| $2.37M | 0.18% |
272,660
-832,275
| -75% | -$7.23M |
|
92
Sotera Health
SHC
$4.54B
| $2.26M | 0.17% |
90,368
+15,750
| +21% | +$393K |
|
93
Regeneron Pharmaceuticals
REGN
$59.8B
| $2.19M | 0.17% |
4,620
| – | – |
|
94
Moderna
MRNA
$9.36B
| $2.08M | 0.16% |
15,850
-110,456
| -87% | -$14.5M |
|
|
ONC
95
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $2.02M | 0.15% |
+5,800
| New | +$2.02M |
|
96
Gilead Sciences
GILD
$140B
| $1.89M | 0.14% |
29,250
-300
| -1% | -$19.4K |
|
97
Illumina
ILMN
$15.2B
| $1.6M | 0.12% |
4,160
+90
| +2% | +$34.4K |
|
98
Zai Lab
ZLAB
$3.48B
| $787K | 0.06% |
5,900
+2,000
| +51% | +$267K |
|
99
Incyte
INCY
$17B
| $667K | 0.05% |
8,210
-430
| -5% | -$34.9K |
|
100
Generation Bio
GBIO
$40.3M
| $613K | 0.05% |
+21,522
| New | +$613K |
|